![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Orthofix’s PhysioStim Bone Growth Stimulator Gains Dual Approval
Orthofix’s PhysioStim Bone Growth Stimulator Gains Dual Approval
![Purple_Approved_Stamp.gif](https://www.fdanews.com/ext/resources/test/Drug-Images4/Purple_Approved_Stamp.gif?t=1576639773&width=430)
March 26, 2018
The FDA and European Commission issued approvals for Orthofix’s PhysioStim bone growth stimulators, a non-surgical treatment for patients with nonunion of a fracture that can be worn over clothing, casts or surgical fixation devices.
By emitting a pulsed electromagnetic field signal, the device prompts a low-level electrical field at the area of fracture and stimulates bone healing. The devices will be available in different models designed to fit the patient’s body.
The devices include a mobile app, STIM onTrack, that allows physicians to remotely view a patient’s adherence to a prescription and allows patients to participate in their recovery through therapy reminders, educational resources and treatment calendars.
Upcoming Events
-
21Oct